Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Elekta AB (publ)
  6. News
  7. Summary
    EKTA B   SE0000163628


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Elekta : acquires Turkish distributor to strengthen market position

09/02/2021 | 01:31am EDT

STOCKHOLM, September 2, 2021 - Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. (Özyürek A.Ş.). The acquisition will improve Elekta's market access in the region and strengthen its relationship with customers.

Cancer of the nervous system is one of the most common types of cancers in the world1. To effectively treat these tumors and other brain disorders, leading healthcare centers around the world choose Leksell Gamma Knife® for its accuracy and documented outcomes. Leksell Gamma Knife® Icon(TM) is the sixth generation of Elekta's Leksell Gamma Knife system and can treat virtually any target in the brain, regardless of type, location or quantity.

Habib Nehme, Executive Vice President Turkey, India, Middle East, Africa, APAC & Japan, says: "For the past 30 years, Özyürek A.Ş. helped establish Leksell Gamma Knife in Turkey and the region with several systems sold. We are especially happy to bring on board the service capabilities and excellence that the Özyürek A.Ş. team has built up. This acquisition will allow us to better focus on the Turkish market and ensure more people living with cancer and brain disorders have access to the most effective and safe treatment they need."

In 2014, Elekta announced the acquisition of its Turkish distributor of linear accelerators, brachytherapy and software. "The neurosurgery business was the last piece of the puzzle, so to speak," adds Nehme. "We expect to now strengthen Elekta's market position and continue our growth in the region through a closer relationship with our customers."

Employees from Özyürek A.Ş. will join Elekta's approximately 70 colleagues working from its offices in Turkey.

1KH. Kalan Farmanfarma , M. Mohammadian , Z. Shahabinia , S. Hassanipour , H. Salehiniya. Brain Cancer in The World: An Epidemiological Review

# # #

For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  
Time zone: CET: Central European Time

Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,400 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter. 



(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about ELEKTA AB (PUBL)
09/02ELEKTA : acquires Turkish distributor to strengthen market position
09/02ELEKTA AB (OM : EKTA B) acquired Özyürek Mümessillik ve Dis Ticaret A.S.
08/31ELEKTA : Unity MR-Linac featured in 72 abstracts at European radiation oncology congress
08/31Elekta Unity MR-Linac Featured in 72 Abstracts At European Radiation Oncology Congress
08/26ELEKTA : Board announces establishment of philanthropic Elekta Foundation
08/26ELEKTA AB (PUBL) : Ex-dividend day for interim dividend
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
08/25ELEKTA : Report from the Annual General Meeting 2021 in Elekta
08/25Elekta AB Approves Dividend, Payable on 1 September 2021 and on 3 March 2022
08/25Elekta AB Resolves on Dividend into Two Payments, Payable on 1 September 2021 and on 3 ..
More news
Sales 2022 14 928 M 1 723 M 1 723 M
Net income 2022 1 363 M 157 M 157 M
Net Debt 2022 889 M 103 M 103 M
P/E ratio 2022 27,6x
Yield 2022 2,10%
Capitalization 37 536 M 4 331 M 4 333 M
EV / Sales 2022 2,57x
EV / Sales 2023 2,37x
Nbr of Employees 4 000
Free-Float 93,8%
Duration : Period :
Elekta AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELEKTA AB (PUBL)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 98,24 SEK
Average target price 118,09 SEK
Spread / Average Target 20,2%
EPS Revisions
Managers and Directors
Gustaf Salford President & Chief Executive Officer
John Adebäck Chief Financial Officer & Group Treasurer
Laurent Leksell Chairman
Steven Mark Wort Chief Operating Officer
Caroline Mofors Chief Compliance & Integrity Office, Senior VP
Sector and Competitors